EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The contribution of ivermectin to the control of onchocerciasis


, : The contribution of ivermectin to the control of onchocerciasis. Cahiers d' Etudes et de Recherches Francophones/Sante 5(3): 149-158

Onchocerciasis is an infection with the nematode Onchocerca volvulus. The main clinical symptoms are caused by the microfilariae. They include ocular lesions leading to blindness. Onchocerciasis is widely distributed in Africa from the Sahara to the southern tip, and is also found in some areas of South and Central America. Ivermectin was shown to be an effective treatment in the early 1980s and is safe and better tolerated than diethylcarbamazine.


Accession: 002980851

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Plaisier, A.P.; Alley, E.S.; Boatin, B.A.; Van Oortmarssen, G.J.; Remme, H.; D.V.as, S.J.; Bonneux, L.; Habbema, J.D., 1995: Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. Ivermectin is an effective drug for the treatment of human onchocerciasis, a disease caused by the parasitic filarial nematode Onchocerca volvulus. When humans are treated, the microfilariae normally found in the skin are rapidly and very nearly c...

Noma, M.; Zouré, H.G.M.; Tekle, A.H.; Enyong, P.A.I.; Nwoke, B.E.B.; Remme, J.H.F., 2015: The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment. The African Programme for Onchocerciasis Control (APOC) was created to control onchocerciasis as a public health problem in 20 African countries. Its main strategy is community directed treatment with ivermectin. In order to identify all high risk...

Banla, Méba.; Tchalim, S.; Karabou, P.K.; Gantin, R.G.; Agba, A.I.; Kére-Banla, A.; Helling-Giese, G.; Heuschkel, C.; Schulz-Key, H.; Soboslay, P.T., 2015: Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study. The evolution and persistence of ocular pathology was assessed in a cohort of Onchocerca volvulus infected patients treated annually with ivermectin for 23 years. Patients were resident in rural Central and Kara Region of Togo and ocular examinati...

Awadzi, K.; Dadzie, K.Y.; Kläger, S.; Gilles, H.M., 1989: The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control. One hundred and ninety eight patients with moderate to heavy infections with Onchocerca volvulus were randomly assigned to receive single doses of 100, 150 or 200 mcg/kg of ivermectin or matching placebo capsules. Detailed systemic, ocular and par...

Bourguinat, C.; Unnasch, T.R.; Prichard, R.K., 2003: Genetic polymorphism in Onchocerca volvulus beta-tubulin prior to the introduction of ivermectin control of Onchocerciasis and following repeated ivermectin treatment. American Journal of Tropical Medicine & Hygiene 69(3 Supplement): 459, September

Tekle, A.Hailemariam.; Elhassan, E.; Isiyaku, S.; Amazigo, U.V.; Bush, S.; Noma, M.; Cousens, S.; Abiose, A.; Remme, J.H., 2014: Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Onchocerciasis can be effectively controlled as a public health problem by annual mass drug administration of ivermectin, but it was not known if ivermectin treatment in the long term would be able to achieve elimination of onchocerciasis infectio...

Chippaux, J.P.; Boussinesq, M.; Prod'hon, J., 1995: The use of ivermectin in the control of onchocerciasis. Onchocerciasis is an infection with the nematode Onchocerca volvulus. The main clinical symptoms are caused by the microfilariae. They include ocular lesions leading to blindness. Onchocerciasis is widely distributed in Africa from the Sahara to t...

Ngoumou, P.; Essomba, R.O.; Godin, C., 1996: Ivermectin-based onchocerciasis control in Cameroon. World Health Forum 17(1): 25-28

Plaisier, A.P.; Alley, E.S.; van Oortmarssen, G.J.; Boatin, B.A.; Habbema, J.D., 1997: Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. In the extension areas of the Onchocerciasis Control Programme in West Africa, aerial larviciding is supplemented with annual ivermectin treatment, mainly to achieve better control of morbidity. The purpose of this study is to determine whether an...

Dadzie, K.Y.; Remme, J.; Sole, G. de; Boatin, B.; Alley, E.S.; Ba, O.; Samba, E.M., 1991: Onchocerciasis control by large-scale ivermectin treatment. The relationship between community microfilarial load (CMFL) and prevalence of blindness due to Onchocerca infection, is discussed with reference to findings made by the Onchocerciasis Control Programme in West Africa. In the savanna, the prevalen...